Home > Drug Shortages, Health Care Policy, Price Controls > Price Controls and Cancer Drug Shortages

Price Controls and Cancer Drug Shortages

The press has reported on the fact that many cancer patients are having difficulty in getting drugs that are needed for the treatment of cancer. The Los Angeles Times has a recent story about the problem but, to an economist, the interesting part of the story is that the LA Times points out that, in 2003, the federal government imposed price controls in the market for these drugs. As any student of introductory economics should know, price controls can lead to shortages.  This fact was illustrated in Part II of my series on economic aspects of Obamacare.  By not allowing the price of a product to clear the market, the result may be a divergence between the quantity that buyers want and the quantity that sellers wish to sell.  It seems quite likely that this intervention by the federal government has a role to play in this drug shortage.

To an economist, price controls are always a bad idea. In the case of this cancer drug shortage, this mistake by the government may well result in the loss of life that need not occur if the market is left to work without these price controls.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Economics One

A blog by John B. Taylor

The Grumpy Economist

One economist's views on economic policy.

The WordPress.com Blog

The latest news on WordPress.com and the WordPress community.

%d bloggers like this: